Company Profiles

driven by the PitchBook Platform

A&G Pharmaceutical

Description

Developer of personalized medicine products designed to treat cancer and other human diseases. The company's personalized medicine products use antibodies to selectively recognize and latch on to the specific cell-surface bio-markers that distinguish diseased cells from normal cells, enabling cancer patients to access personalized care facilities.

2000

Founded

PRIVATE

Status

Grant

Latest Deal Type

$3.34M

Latest Deal Amount

$5.4M

Total Amount Raised

16

Investors

Description

Developer of personalized medicine products designed to treat cancer and other human diseases. The company's personalized medicine products use antibodies to selectively recognize and latch on to the specific cell-surface bio-markers that distinguish diseased cells from normal cells, enabling cancer patients to access personalized care facilities.

Website:

www.agpharma.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

9130 Red Branch Road Suite U Columbia, MD 21045United States +1 (410) 884-4100
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore A&G Pharmaceutical's full profile, request a free trial.

    A&G Pharmaceutical Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    A&G Pharmaceutical Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    A&G Pharmaceutical Investors (16)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    ASM ResourcesVenture CapitalMinority000 0000000 0000
    Avon Foundation for WomenOther000 0000000 0000
    CelltrionOtherMinority000 0000000 0000
    Crocker CapitalVenture CapitalMinority000 0000000 0000
    Emerge CapitalPE/BuyoutMinority000 0000000 0000
    ASM Resources Venture Capital
    Avon Foundation for Women Other
    Celltrion Other
    Crocker Capital Venture Capital
    Emerge Capital PE/Buyout

    A&G Pharmaceutical Executive Team (6)

    NameTitleBoard
    Seat
    Contact
    Info
    Ginette Serrero Ph.DCo-Founder, Chief Executive Officer & Board Member
    Michael KeefeChief Operating Officer
    David HicksDirector, Product Development
    Jun Hayashi Ph.DCo-Founder & Vice President, Research & Development
    Gordon Sato Ph.DCo-Founder, Chairman and Scientific Advisor
    Ginette Serrero Ph.D Co-Founder, Chief Executive Officer & Board Member
    Michael Keefe Chief Operating Officer
    David Hicks Director, Product Development
    Jun Hayashi Ph.D Co-Founder & Vice President, Research & Development
    Gordon Sato Ph.D Co-Founder, Chairman and Scientific Advisor

    A&G Pharmaceutical Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    Ginette Serrero Ph.DA&G PharmaceuticalCo-Founder, Chief Executive Officer & Board Member000 0000
    Gordon Sato Ph.DA&G PharmaceuticalCo-Founder, Chairman and Scientific Advisor000 0000
    Lars HananBroadOak Capital PartnersCo-Founder & Partner000 0000
    SeungSuh HongCelltrionPresident, Research & Development000 0000
    Tom HancockNew England PartnersPrincipal000 0000
    Ginette Serrero Ph.D Co-Founder, Chief Executive Officer & Board Member A&G Pharmaceutical
    Gordon Sato Ph.D Co-Founder, Chairman and Scientific Advisor A&G Pharmaceutical
    Lars Hanan Co-Founder & Partner BroadOak Capital Partners
    SeungSuh Hong President, Research & Development Celltrion
    Tom Hancock Principal New England Partners
    Request full access to PitchBook